SLIMObesity ETF

$0.00
$0.00
(0.00%)
Today
Updated:
News
all
press releases
News Placeholder
Eli Lilly Stock Eyes Best Month This Year As Cholesterol, Obesity Drug Tailwinds Build
LLY's stock is still down year-to-date as AI-driven narratives have captured the bulk of investor attention and capital in 2026.
Stocktwits
<
...
1
>
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.